176 related articles for article (PubMed ID: 34722809)
1. Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution.
Williams VM; Parvathaneni U; Laramore GE; Aljabab S; Wong TP; Liao JJ
Int J Part Ther; 2021; 8(2):28-40. PubMed ID: 34722809
[TBL] [Abstract][Full Text] [Related]
2. Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington.
Aljabab S; Liu A; Wong T; Liao JJ; Laramore GE; Parvathaneni U
Int J Part Ther; 2020; 6(3):1-12. PubMed ID: 32582809
[TBL] [Abstract][Full Text] [Related]
3. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Bhangoo RS; DeWees TA; Yu NY; Ding JX; Liu C; Golafshar MA; Rule WG; Vora SA; Ross HJ; Ahn DH; Beamer SE; Jaroszewski DE; Hallemeier CL; Liu W; Ashman JB; Sio TT
Adv Radiat Oncol; 2020; 5(5):871-879. PubMed ID: 33083649
[TBL] [Abstract][Full Text] [Related]
4. Esophageal Cancer Outcomes After Definitive Chemotherapy With Intensity Modulated Proton Therapy.
Abana CO; Damen PJ; van Rossum PS; Bravo PL; Wei X; Pollard-Larkin JM; Nitsch PL; Murphy MB; Hofstetter WL; Liao Z; Lin SH
Int J Part Ther; 2024 Mar; 11():100009. PubMed ID: 38757075
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma.
Holliday E; Bhattasali O; Kies MS; Hanna E; Garden AS; Rosenthal DI; Morrison WH; Gunn GB; Phan J; Zhu XR; Zhang X; Frank SJ
Int J Part Ther; 2016 Mar; 2(4):533-543. PubMed ID: 31772965
[TBL] [Abstract][Full Text] [Related]
6. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
8. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience.
Yu NY; DeWees TA; Liu C; Daniels TB; Ashman JB; Beamer SE; Jaroszewski DE; Ross HJ; Paripati HR; Rwigema JM; Ding JX; Shan J; Liu W; Schild SE; Sio TT
Adv Radiat Oncol; 2020; 5(3):450-458. PubMed ID: 32529140
[TBL] [Abstract][Full Text] [Related]
9. Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results.
Jiří K; Vladimír V; Michal A; Matěj N; Silvia S; Pavel V; Kateřina D; Jana P; Barbora O; Eliška R; Petr L; Matěj P; Alexander G; Jozef R
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):763-769. PubMed ID: 32623508
[TBL] [Abstract][Full Text] [Related]
10. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
[No Abstract] [Full Text] [Related]
11. Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.
Tang JM; Ma XM; Hou YL; Dai LY; Cao HB; Ye M; Bai YR
J Radiat Res; 2014 Jul; 55(4):794-802. PubMed ID: 24614820
[TBL] [Abstract][Full Text] [Related]
12. Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer.
Park SG; Ahn YC; Oh D; Noh JM; Ju SG; Kwon D; Jo K; Chung K; Chung E; Lee W; Park S
Cancer Sci; 2019 Sep; 110(9):2867-2874. PubMed ID: 31237050
[TBL] [Abstract][Full Text] [Related]
13. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
[TBL] [Abstract][Full Text] [Related]
16. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience.
Prayongrat A; Xu C; Li H; Lin SH
Adv Radiat Oncol; 2017; 2(3):301-307. PubMed ID: 29114596
[TBL] [Abstract][Full Text] [Related]
18. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
